Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,146 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +4.7%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 1,301–1,350 of 2,146 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01730638	ImmunoTEP for Patients With Medullary Thyroid Carcinoma.(iTEP-CMT)	completed	Phase 1 / Phase 2	25	Nantes University HospitalOTHER	1	Jul 26, 2022	clinicaltrials
NCT03065218	99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients	terminated	Phase 4	4	Medstar Health Research InstituteOTHER	1	Jul 26, 2022	clinicaltrials